Dendreon (DNDN)
Add to Watchlists Create an Alert
3.89
-0.02 -0.51%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Dendreon Revenue Quarterly YoY Growth:
-17.64% for March 31, 2013Dendreon Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -17.64% |
| Dec. 31, 2012 | -57.71% |
| Sept. 30, 2012 | 21.29% |
| June 30, 2012 | 66.10% |
| March 31, 2012 | 203.7% |
| Dec. 31, 2011 | 708.4% |
| Sept. 30, 2011 | 218.0% |
| June 30, 2011 | 1614% |
| March 31, 2011 | 128576% |
| Dec. 31, 2010 | 118981% |
| Sept. 30, 2010 | 80776% |
| June 30, 2010 | 11140% |
| March 31, 2010 | -30.00% |
| Dec. 31, 2009 | -25.00% |
| Sept. 30, 2009 | -3.85% |
| June 30, 2009 | -3.85% |
| March 31, 2009 | -3.23% |
| Dec. 31, 2008 | 0.00% |
| Sept. 30, 2008 | -76.79% |
| June 30, 2008 | -95.03% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
DNDN Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Medivation | 148.7% |
| Johnson & Johnson | 8.46% |
| Targacept | -84.53% |
DNDN Revenue Quarterly YoY Growth Rankings
| Overall |
40th percentile 4770 of 8009 |
| Sector |
30th percentile 478 of 687 in Healthcare |
| Industry |
58th percentile 103 of 248 in Biotechnology |
DNDN Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -95.03% | Jun 2008 |
| Maximum | 128576% | Mar 2011 |
| Average | 17100% |
